Won Sik Lee, MD, Ph.D

Chief Executive Officer

• Former Director General of Pharmaceutical Safety Bureau at Korea Ministry of Food and Drug Safety

• Involved in R&D and regulatory reform, ICH and IFAPP management committee,  Leadership roles  in various Pharmaceutical Medicine Society (e.g. KSCPT, KSPM, KSME)

• Worked over 20 years  for various Pharmaceuticals as Medical/Scientific Affairs Director at MSD,  Sanofi,  Handok, and Pfizer

• Ph.D. in Pharmacology at Hanyang University

• MS of Preventive Medicine at Seoul National University

• Bachelor of Medicine at Seoul National University

Alan Choi, MD

Chief Science Officer

• Head of Research and Development at Ildong Pharmaceutical Co., Ltd.

• CEO at AIMS BioScience, a subsidiary company of Ildong Group 

• Chairman of Korea Society of Pharmaceutical Medicine

• Multiple roles of prior company as an executive director at J&J Korea, engaged in various R&D projects, clinical operations, medical advisor and commercial unit

• Adjunctive Professor at Youth and Child psychiatry at SMC (Samsung Medical Center), served as medical director at National Center for Mental Health

• Bachelor of Medicine at Seoul National University

Jinsik Suh,  MBA

Chief Finance Officer

• Chief Operating Officer at Ildong Pharmaceutical Co., Ltd.

• Former Chief Finance Officer at Dongwon F&B and Janssen Korea (Johnson & Johnson) with multi-disciplinary project , supply chain improvement and optimizing back office operation

• MBA, Darden School of Business at University of Virginia, CPA (Certified Public Accountant) in Maryland, US

• Bachelor of Business Administration at Seoul National University

Eun-Jihn Roh, R.Ph, M.S

Chief Development Officer

• Total 15 years of industry experience, of which more than 10 years have been solely dedicated to Oncology clinical development

• Former Oncology Project Lead at Pfizer Korea

• Former Oncology Project Manager, Project Director and Customer Relationship Executive at Syneos Health

• Provided consultancy to numerous oncology biotechs

• Bachelor’s degree in pharmaceutical studies and master’s degree in pharmacology at Ewha Woman’s University

• Registered pharmacist

Kyoung Soo Ha, MD, Ph.D.

Chief Medical Officer

• 15 years of industry experience, including 7 years of  medical lead of multinational clinical trials in hemato-oncology area

• Early / late phase global clinical development for oncology area as Sr. Medical Director / Chief Medical Officer at Sillajen and Archigen

• Medical Affairs Director for diverse therapeutic area including cardiovascular metabolism and immunology at Sanofi, Novartis, and Abbott

• Multiple hands-on experience of clinical trial start-ups from synopsis development into regulatory IND approval in Korea, US and EU

• Ph.D. of Public Health (Epideimiology) & Bachelor of Medicine at Yonsei University